Eczema: quality of life by body site and the effect of patch testing

Summary Background Patients with dermatitis are known to have impaired quality of life. Whether this varies according to body site has not been evaluated. Patch tests have previously been shown to influence quality of life, although no previous studies have shown if this is dependent on the results...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:British journal of dermatology (1951) 2002-04, Vol.146 (4), p.627-630
Hauptverfasser: Thomson, K.F., Wilkinson, S.M., Sommer, S., Pollock, B.
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 630
container_issue 4
container_start_page 627
container_title British journal of dermatology (1951)
container_volume 146
creator Thomson, K.F.
Wilkinson, S.M.
Sommer, S.
Pollock, B.
description Summary Background Patients with dermatitis are known to have impaired quality of life. Whether this varies according to body site has not been evaluated. Patch tests have previously been shown to influence quality of life, although no previous studies have shown if this is dependent on the results of the patch tests. Objectives To evaluate the impact of patch testing on quality of life according to the outcome of the investigations and to determine how quality of life varies according to eczema body site. Methods One hundred and sixty consecutive adult patients with active eczema were selected from a patch test clinic for inclusion into the study. Quality of life was determined using the Dermatology Life Quality Index (DLQI) and the SF‐36, prior to patch testing and 2 months later. Perceived eczema severity at each time point was also noted, along with the outcome of patch testing. Baseline comparison of quality of life was performed between four body site groups (face, hand, generalized, other). Results Patients confirmed as having relevant positive contact allergens were shown to have a significant improvement in both perceived eczema severity (P = 0·0004) and DLQI score (P = 0·0015) at 2 months after patch testing. No significant changes were noted in the SF‐36 score, other than a borderline improvement in the pain score (P = 0·048). The improvement in quality of life and eczema severity was not noted in patients with negative patch tests. Eighty‐nine per cent of patients diagnosed as having contact allergy were able to comply with avoidance advice. No significant variation was noted in quality of life according to body site affected by eczema. There was a positive correlation between DLQI score and perceived eczema severity (P 
doi_str_mv 10.1046/j.1365-2133.2002.04692.x
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_71615454</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>125366191</sourcerecordid><originalsourceid>FETCH-LOGICAL-c4602-f9c24f90c4b3979d70f40c8808e5b7a52d79a845a8b6d75a47f3a8f47c57757b3</originalsourceid><addsrcrecordid>eNqNkMtu1DAYhS0EotOWV0AWEt0l-H5BYtEbLagtGy4SG8txbOohk0zjREz69HWYUSuxYmXL_r7z_zoAQIxKjJh4tywxFbwgmNKSIETK_KhJuXkGFo8fz8ECISQLpAXdA_spLRHCFHH0EuxhrIUQmi3A2bm79yv7Ht6NtonDBLsAmxg8rCZYdfUEUxw8tG0Nh1sPfQjeDTOztoO7hYNPQ2x_HYIXwTbJv9qdB-Dbx_Ovp5fF1ZeLT6fHV4VjApEiaEdY0Miximqpa4kCQ04ppDyvpOWkltoqxq2qRC25ZTJQqwKTjkvJZUUPwNE2d913d2OebVYxOd80tvXdmIzEAnPGWQbf_AMuu7Fv824m14UxZQpnSG0h13cp9T6YdR9Xtp8MRmau2SzN3KaZ25w9Yv7WbDZZfb3LH6uVr5_EXa8ZeLsDbHK2Cb1tXUxPXI6lWpHMfdhyf2Ljp_9ewJx8Pptv2S-2fkyD3zz6tv9thKSSmx83F0ZeXt_Ik5_EfKcPKqSkrw</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>200113481</pqid></control><display><type>article</type><title>Eczema: quality of life by body site and the effect of patch testing</title><source>Wiley Online Library - AutoHoldings Journals</source><source>MEDLINE</source><source>Oxford University Press Journals All Titles (1996-Current)</source><creator>Thomson, K.F. ; Wilkinson, S.M. ; Sommer, S. ; Pollock, B.</creator><creatorcontrib>Thomson, K.F. ; Wilkinson, S.M. ; Sommer, S. ; Pollock, B.</creatorcontrib><description>Summary Background Patients with dermatitis are known to have impaired quality of life. Whether this varies according to body site has not been evaluated. Patch tests have previously been shown to influence quality of life, although no previous studies have shown if this is dependent on the results of the patch tests. Objectives To evaluate the impact of patch testing on quality of life according to the outcome of the investigations and to determine how quality of life varies according to eczema body site. Methods One hundred and sixty consecutive adult patients with active eczema were selected from a patch test clinic for inclusion into the study. Quality of life was determined using the Dermatology Life Quality Index (DLQI) and the SF‐36, prior to patch testing and 2 months later. Perceived eczema severity at each time point was also noted, along with the outcome of patch testing. Baseline comparison of quality of life was performed between four body site groups (face, hand, generalized, other). Results Patients confirmed as having relevant positive contact allergens were shown to have a significant improvement in both perceived eczema severity (P = 0·0004) and DLQI score (P = 0·0015) at 2 months after patch testing. No significant changes were noted in the SF‐36 score, other than a borderline improvement in the pain score (P = 0·048). The improvement in quality of life and eczema severity was not noted in patients with negative patch tests. Eighty‐nine per cent of patients diagnosed as having contact allergy were able to comply with avoidance advice. No significant variation was noted in quality of life according to body site affected by eczema. There was a positive correlation between DLQI score and perceived eczema severity (P &lt; 0·0001). Conclusions Patients confirmed as having contact allergy show a subsequent improvement in eczema severity and an improvement in quality of life.</description><identifier>ISSN: 0007-0963</identifier><identifier>EISSN: 1365-2133</identifier><identifier>DOI: 10.1046/j.1365-2133.2002.04692.x</identifier><identifier>PMID: 11966694</identifier><identifier>CODEN: BJDEAZ</identifier><language>eng</language><publisher>Oxford, UK: Blackwell Science Ltd</publisher><subject>Adolescent ; Adult ; Aged ; Allergic diseases ; Biological and medical sciences ; body site ; contact allergy ; Dermatitis, Allergic Contact - diagnosis ; Dermatitis, Allergic Contact - pathology ; Dermatitis, Allergic Contact - rehabilitation ; eczema ; Eczema - pathology ; Eczema - rehabilitation ; Female ; Follow-Up Studies ; Humans ; Immunopathology ; Linear Models ; Male ; Medical sciences ; Middle Aged ; Patch Tests ; Quality of Life ; Severity of Illness Index ; Skin allergic diseases. Stinging insect allergies</subject><ispartof>British journal of dermatology (1951), 2002-04, Vol.146 (4), p.627-630</ispartof><rights>2002 INIST-CNRS</rights><rights>Copyright Blackwell Scientific Publications Ltd. Apr 2002</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c4602-f9c24f90c4b3979d70f40c8808e5b7a52d79a845a8b6d75a47f3a8f47c57757b3</citedby><cites>FETCH-LOGICAL-c4602-f9c24f90c4b3979d70f40c8808e5b7a52d79a845a8b6d75a47f3a8f47c57757b3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://onlinelibrary.wiley.com/doi/pdf/10.1046%2Fj.1365-2133.2002.04692.x$$EPDF$$P50$$Gwiley$$H</linktopdf><linktohtml>$$Uhttps://onlinelibrary.wiley.com/doi/full/10.1046%2Fj.1365-2133.2002.04692.x$$EHTML$$P50$$Gwiley$$H</linktohtml><link.rule.ids>315,781,785,1418,27929,27930,45579,45580</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&amp;idt=13653982$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/11966694$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Thomson, K.F.</creatorcontrib><creatorcontrib>Wilkinson, S.M.</creatorcontrib><creatorcontrib>Sommer, S.</creatorcontrib><creatorcontrib>Pollock, B.</creatorcontrib><title>Eczema: quality of life by body site and the effect of patch testing</title><title>British journal of dermatology (1951)</title><addtitle>Br J Dermatol</addtitle><description>Summary Background Patients with dermatitis are known to have impaired quality of life. Whether this varies according to body site has not been evaluated. Patch tests have previously been shown to influence quality of life, although no previous studies have shown if this is dependent on the results of the patch tests. Objectives To evaluate the impact of patch testing on quality of life according to the outcome of the investigations and to determine how quality of life varies according to eczema body site. Methods One hundred and sixty consecutive adult patients with active eczema were selected from a patch test clinic for inclusion into the study. Quality of life was determined using the Dermatology Life Quality Index (DLQI) and the SF‐36, prior to patch testing and 2 months later. Perceived eczema severity at each time point was also noted, along with the outcome of patch testing. Baseline comparison of quality of life was performed between four body site groups (face, hand, generalized, other). Results Patients confirmed as having relevant positive contact allergens were shown to have a significant improvement in both perceived eczema severity (P = 0·0004) and DLQI score (P = 0·0015) at 2 months after patch testing. No significant changes were noted in the SF‐36 score, other than a borderline improvement in the pain score (P = 0·048). The improvement in quality of life and eczema severity was not noted in patients with negative patch tests. Eighty‐nine per cent of patients diagnosed as having contact allergy were able to comply with avoidance advice. No significant variation was noted in quality of life according to body site affected by eczema. There was a positive correlation between DLQI score and perceived eczema severity (P &lt; 0·0001). Conclusions Patients confirmed as having contact allergy show a subsequent improvement in eczema severity and an improvement in quality of life.</description><subject>Adolescent</subject><subject>Adult</subject><subject>Aged</subject><subject>Allergic diseases</subject><subject>Biological and medical sciences</subject><subject>body site</subject><subject>contact allergy</subject><subject>Dermatitis, Allergic Contact - diagnosis</subject><subject>Dermatitis, Allergic Contact - pathology</subject><subject>Dermatitis, Allergic Contact - rehabilitation</subject><subject>eczema</subject><subject>Eczema - pathology</subject><subject>Eczema - rehabilitation</subject><subject>Female</subject><subject>Follow-Up Studies</subject><subject>Humans</subject><subject>Immunopathology</subject><subject>Linear Models</subject><subject>Male</subject><subject>Medical sciences</subject><subject>Middle Aged</subject><subject>Patch Tests</subject><subject>Quality of Life</subject><subject>Severity of Illness Index</subject><subject>Skin allergic diseases. Stinging insect allergies</subject><issn>0007-0963</issn><issn>1365-2133</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2002</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNqNkMtu1DAYhS0EotOWV0AWEt0l-H5BYtEbLagtGy4SG8txbOohk0zjREz69HWYUSuxYmXL_r7z_zoAQIxKjJh4tywxFbwgmNKSIETK_KhJuXkGFo8fz8ECISQLpAXdA_spLRHCFHH0EuxhrIUQmi3A2bm79yv7Ht6NtonDBLsAmxg8rCZYdfUEUxw8tG0Nh1sPfQjeDTOztoO7hYNPQ2x_HYIXwTbJv9qdB-Dbx_Ovp5fF1ZeLT6fHV4VjApEiaEdY0Miximqpa4kCQ04ppDyvpOWkltoqxq2qRC25ZTJQqwKTjkvJZUUPwNE2d913d2OebVYxOd80tvXdmIzEAnPGWQbf_AMuu7Fv824m14UxZQpnSG0h13cp9T6YdR9Xtp8MRmau2SzN3KaZ25w9Yv7WbDZZfb3LH6uVr5_EXa8ZeLsDbHK2Cb1tXUxPXI6lWpHMfdhyf2Ljp_9ewJx8Pptv2S-2fkyD3zz6tv9thKSSmx83F0ZeXt_Ik5_EfKcPKqSkrw</recordid><startdate>200204</startdate><enddate>200204</enddate><creator>Thomson, K.F.</creator><creator>Wilkinson, S.M.</creator><creator>Sommer, S.</creator><creator>Pollock, B.</creator><general>Blackwell Science Ltd</general><general>Blackwell</general><general>Oxford University Press</general><scope>BSCLL</scope><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7T5</scope><scope>H94</scope><scope>K9.</scope><scope>NAPCQ</scope><scope>7X8</scope></search><sort><creationdate>200204</creationdate><title>Eczema: quality of life by body site and the effect of patch testing</title><author>Thomson, K.F. ; Wilkinson, S.M. ; Sommer, S. ; Pollock, B.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c4602-f9c24f90c4b3979d70f40c8808e5b7a52d79a845a8b6d75a47f3a8f47c57757b3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2002</creationdate><topic>Adolescent</topic><topic>Adult</topic><topic>Aged</topic><topic>Allergic diseases</topic><topic>Biological and medical sciences</topic><topic>body site</topic><topic>contact allergy</topic><topic>Dermatitis, Allergic Contact - diagnosis</topic><topic>Dermatitis, Allergic Contact - pathology</topic><topic>Dermatitis, Allergic Contact - rehabilitation</topic><topic>eczema</topic><topic>Eczema - pathology</topic><topic>Eczema - rehabilitation</topic><topic>Female</topic><topic>Follow-Up Studies</topic><topic>Humans</topic><topic>Immunopathology</topic><topic>Linear Models</topic><topic>Male</topic><topic>Medical sciences</topic><topic>Middle Aged</topic><topic>Patch Tests</topic><topic>Quality of Life</topic><topic>Severity of Illness Index</topic><topic>Skin allergic diseases. Stinging insect allergies</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Thomson, K.F.</creatorcontrib><creatorcontrib>Wilkinson, S.M.</creatorcontrib><creatorcontrib>Sommer, S.</creatorcontrib><creatorcontrib>Pollock, B.</creatorcontrib><collection>Istex</collection><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Immunology Abstracts</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>Nursing &amp; Allied Health Premium</collection><collection>MEDLINE - Academic</collection><jtitle>British journal of dermatology (1951)</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Thomson, K.F.</au><au>Wilkinson, S.M.</au><au>Sommer, S.</au><au>Pollock, B.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Eczema: quality of life by body site and the effect of patch testing</atitle><jtitle>British journal of dermatology (1951)</jtitle><addtitle>Br J Dermatol</addtitle><date>2002-04</date><risdate>2002</risdate><volume>146</volume><issue>4</issue><spage>627</spage><epage>630</epage><pages>627-630</pages><issn>0007-0963</issn><eissn>1365-2133</eissn><coden>BJDEAZ</coden><abstract>Summary Background Patients with dermatitis are known to have impaired quality of life. Whether this varies according to body site has not been evaluated. Patch tests have previously been shown to influence quality of life, although no previous studies have shown if this is dependent on the results of the patch tests. Objectives To evaluate the impact of patch testing on quality of life according to the outcome of the investigations and to determine how quality of life varies according to eczema body site. Methods One hundred and sixty consecutive adult patients with active eczema were selected from a patch test clinic for inclusion into the study. Quality of life was determined using the Dermatology Life Quality Index (DLQI) and the SF‐36, prior to patch testing and 2 months later. Perceived eczema severity at each time point was also noted, along with the outcome of patch testing. Baseline comparison of quality of life was performed between four body site groups (face, hand, generalized, other). Results Patients confirmed as having relevant positive contact allergens were shown to have a significant improvement in both perceived eczema severity (P = 0·0004) and DLQI score (P = 0·0015) at 2 months after patch testing. No significant changes were noted in the SF‐36 score, other than a borderline improvement in the pain score (P = 0·048). The improvement in quality of life and eczema severity was not noted in patients with negative patch tests. Eighty‐nine per cent of patients diagnosed as having contact allergy were able to comply with avoidance advice. No significant variation was noted in quality of life according to body site affected by eczema. There was a positive correlation between DLQI score and perceived eczema severity (P &lt; 0·0001). Conclusions Patients confirmed as having contact allergy show a subsequent improvement in eczema severity and an improvement in quality of life.</abstract><cop>Oxford, UK</cop><pub>Blackwell Science Ltd</pub><pmid>11966694</pmid><doi>10.1046/j.1365-2133.2002.04692.x</doi><tpages>4</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0007-0963
ispartof British journal of dermatology (1951), 2002-04, Vol.146 (4), p.627-630
issn 0007-0963
1365-2133
language eng
recordid cdi_proquest_miscellaneous_71615454
source Wiley Online Library - AutoHoldings Journals; MEDLINE; Oxford University Press Journals All Titles (1996-Current)
subjects Adolescent
Adult
Aged
Allergic diseases
Biological and medical sciences
body site
contact allergy
Dermatitis, Allergic Contact - diagnosis
Dermatitis, Allergic Contact - pathology
Dermatitis, Allergic Contact - rehabilitation
eczema
Eczema - pathology
Eczema - rehabilitation
Female
Follow-Up Studies
Humans
Immunopathology
Linear Models
Male
Medical sciences
Middle Aged
Patch Tests
Quality of Life
Severity of Illness Index
Skin allergic diseases. Stinging insect allergies
title Eczema: quality of life by body site and the effect of patch testing
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-12T04%3A09%3A20IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Eczema:%20quality%20of%20life%20by%20body%20site%20and%20the%20effect%20of%20patch%20testing&rft.jtitle=British%20journal%20of%20dermatology%20(1951)&rft.au=Thomson,%20K.F.&rft.date=2002-04&rft.volume=146&rft.issue=4&rft.spage=627&rft.epage=630&rft.pages=627-630&rft.issn=0007-0963&rft.eissn=1365-2133&rft.coden=BJDEAZ&rft_id=info:doi/10.1046/j.1365-2133.2002.04692.x&rft_dat=%3Cproquest_cross%3E125366191%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=200113481&rft_id=info:pmid/11966694&rfr_iscdi=true